Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Powers-Weightman-Rosengarten (PWR) was a prominent American pharmaceutical and chemical manufacturer based in Philadelphia. The company was a leading producer of quinine, an essential treatment for malaria, and other medicinal chemicals during the 19th and early 20th centuries. In 1927, the company merged with Merck & Co., significantly expanding Merck's manufacturing capabilities and market presence in the United States. This merger was a pivotal moment in the history of the American pharmaceutical industry, helping to establish Merck as a dominant global player. Frederic Rosengarten, a key figure in the company, subsequently served as the chairman of the board for Merck & Co.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rosengarten.